Magnet Biomedicine and Lilly link for molecular glue therapeutics
Magnet Biomedicine has entered a partnership and licence agreement with Eli Lilly to discover, develop and commercialise ...
Magnet Biomedicine Enters into a Collaboration and License Agreement with Lilly to Discover and Develop Novel Molecular Glue Medicines
Magnet Biomedicine, a leading biopharmaceutical company advancing molecular glue discovery with rational selection and design ...
Eli Lilly in pact with Magnet Bio to develop cancer drugs in a deal worth up to $1.25B
Eli Lilly (LLY) joins hands with Magnet Biomedicine in a deal worth up to $1.25B to develop cancer drugs using Magnet's ...
FierceBiotech3d
Eli Lilly feels Magnet's pull with molecular glue deal potentially worth $1.25B
The molecular glue wave that first began years ago is still swelling, with Eli Lilly earmarking approximately $1.25 billion ...
BioWorld2d
Magnet, Eli Lilly sign $1.25B molecular glue deal for oncology
About 17 months after emerging from stealth with its Trueglue discovery platform, Magnet Biomedicine Inc. has joined with Eli ...
Contract Pharma2d
Magnet Biomedicine & Lilly Partner on Molecular Glue Oncology Therapies
Magnet Biomedicine, a biopharmaceutical company advancing molecular glue discovery, has entered a collaboration and license ...
The Pharma Letter1d
Lilly attracted to molecular glue space via deal with Magnet
Massachusetts, USA-based start-up Magnet Biomedicine, which is advancing molecular glue discovery with rational selection and ...
BioSpace2d
Lilly Hops On Hot Molecular Glue Train With $1.2B+ Magnet Deal
The molecular glue space has attracted several Big Pharma players over the past few years, including Novo Nordisk, Pfizer and ...
Jim Cramer on Eli Lilly and Company (LLY): ‘Eli Lilly Cutting The Price Is Gonna Make It So That It Is Dramatically Good’
We recently published an article titled Jim Cramer Discusses These 10 Stocks & Says Bitcoin Created "Froth" In The Market. In ...
Morningstar3d
Magnet Biomedicine Enters into a Collaboration and License Agreement with Lilly to Discover and Develop Novel Molecular Glue Medicines
BOSTON, Feb. 28, 2025 /PRNewswire/ -- Magnet Biomedicine ... today announced a collaboration and license agreement with Eli Lilly and Company to discover, develop, and commercialize molecular ...